Search results
Emcure Pharma Backed By Bain Capital Mobilises ₹583 Crore From Anchor Investors
Free Press Journal· 3 days agoBain Capital-backed Emcure Pharmaceuticals on Tuesday said it has garnered Rs 583 crore from anchor...
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 5 days agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Emcure Pharmaceuticals IPO: Bain Capital backed firm raises ₹582 crore from anchor investors ahead...
Livemint· 3 days agoAccording to the exchange filing, the company has allocated 57,79,850 shares to 48 anchor investors...
Bain-backed Emcure Pharma attracts bids worth $11 bn in IPO
VCCircle· 15 hours agoVCCircle is India leading source Latest Indian Financial News,Startup Funding,Real Estate,Funding...
Bain’s India lender plans to double portfolio ahead of listing
CNBC Awaaz· 3 days agoTyger Capital Pvt Ltd., the Indian shadow lender Bain Capital bought from the Adani Group, is...
Tyger Capital to list by next year, targets Rs 20,000 crore book
Business Standard India· 1 day agoTyger Capital: Gaurav Gupta said that in keeping with growing business, company expects to take on...
Emcure Pharma IPO Opens Today: Should You Subscribe? Check Price, GMP, Lot Size, Recommendations -...
News18· 3 days agoEmcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by ...
Emcure Pharma IPO: GMP surges on last day; issue subscribed 24 times so far - CNBC TV18
CNBC TV18· 13 hours agoThe initial share sale of Emcure Pharmaceuticals was off to a strong start on the last day of the...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 3 days agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 1 day agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...